127 related articles for article (PubMed ID: 30074239)
21. Antifungal prophylaxis in newly diagnosed AML patients-Adherence to guidelines and feasibility in a real life setting.
Berking S; Doedens D; Horns H; Fiegl M; Ostermann H; Rieger CT
Mycoses; 2017 Sep; 60(9):600-606. PubMed ID: 28504318
[TBL] [Abstract][Full Text] [Related]
22. Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia.
Ganti BR; Marini BL; Nagel J; Bixby D; Perissinotti AJ
Support Care Cancer; 2017 Feb; 25(2):541-547. PubMed ID: 27738797
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
[TBL] [Abstract][Full Text] [Related]
24. Guideline recommendations for the prophylaxis of invasive aspergillosis in AML.
Wang ES
Clin Adv Hematol Oncol; 2016 Nov; 14(11):876-879. PubMed ID: 27930638
[No Abstract] [Full Text] [Related]
25. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Mellinghoff SC; Panse J; Alakel N; Behre G; Buchheidt D; Christopeit M; Hasenkamp J; Kiehl M; Koldehoff M; Krause SW; Lehners N; von Lilienfeld-Toal M; Löhnert AY; Maschmeyer G; Teschner D; Ullmann AJ; Penack O; Ruhnke M; Mayer K; Ostermann H; Wolf HH; Cornely OA
Ann Hematol; 2018 Feb; 97(2):197-207. PubMed ID: 29218389
[TBL] [Abstract][Full Text] [Related]
26. Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia.
Felsenstein S; Orgel E; Rushing T; Fu C; Hoffman JA
Pediatr Infect Dis J; 2015 Apr; 34(4):e78-84. PubMed ID: 25764103
[TBL] [Abstract][Full Text] [Related]
27. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
[TBL] [Abstract][Full Text] [Related]
28. Infections in patients with acute myeloid leukemia treated with low-intensity therapeutic regimens: Risk factors and efficacy of antibiotic prophylaxis.
Bainschab A; Quehenberger F; Greinix HT; Krause R; Wölfler A; Sill H; Zebisch A
Leuk Res; 2016 Mar; 42():47-51. PubMed ID: 26866663
[TBL] [Abstract][Full Text] [Related]
29. Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
Al-Badriyeh D; Slavin M; Liew D; Thursky K; Downey M; Grigg A; Bajel A; Stewart K; Kong DC
J Antimicrob Chemother; 2010 May; 65(5):1052-61. PubMed ID: 20237074
[TBL] [Abstract][Full Text] [Related]
30. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country.
Korula A; Abraham A; Abubacker FN; Viswabandya A; Lakshmi KM; Abraham OC; Rupali P; Varghese GM; Michael JS; Srivastava A; Mathews V; George B
Mycoses; 2017 Oct; 60(10):686-691. PubMed ID: 28736936
[TBL] [Abstract][Full Text] [Related]
31. Clinical effectiveness of itraconazole as antifungal prophylaxis in AML patients undergoing intensive chemotherapy in the modern era.
Keighley CL; Manii P; Larsen SR; van Hal S
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):213-217. PubMed ID: 27830376
[TBL] [Abstract][Full Text] [Related]
32. Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
Yunus S; Pieper S; Kolve H; Goletz G; Jürgens H; Groll AH
J Antimicrob Chemother; 2014 Mar; 69(3):815-20. PubMed ID: 24198097
[TBL] [Abstract][Full Text] [Related]
33. Infective endocarditis prophylaxis: current practice trend among paediatric cardiologists: are we following the 2007 guidelines?
Naik RJ; Patel NR; Wang M; Shah NC
Cardiol Young; 2016 Aug; 26(6):1176-82. PubMed ID: 26715655
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic Prophylaxis and Resistance in Surgical Site Infection After Immediate Tissue Expander Reconstruction of the Breast.
McCullough MC; Chu CK; Duggal CS; Losken A; Carlson GW
Ann Plast Surg; 2016 Nov; 77(5):501-505. PubMed ID: 25003455
[TBL] [Abstract][Full Text] [Related]
35. The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study.
Özkocaman V; Özkalemkaş F; Seyhan S; Ener B; Ursavaş A; Ersal T; Kazak E; Demirdöğen E; Mıstık R; Akalın H
Turk J Haematol; 2018 Nov; 35(4):277-282. PubMed ID: 30047484
[TBL] [Abstract][Full Text] [Related]
36. Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group.
Kimura SI; Fujita H; Handa H; Hiramoto N; Hosono N; Minamiguchi H; Takahashi T; Kato H; Ono T; Kanda Y; Kiyoi H; Matsumura I; Miyazaki Y;
Int J Hematol; 2020 Sep; 112(3):409-417. PubMed ID: 32557124
[TBL] [Abstract][Full Text] [Related]
37. [Prophylaxis of invasive fungal infection with different administration regimens of itraconazole in patients with acute myeloid leukemia: a report from a randomized, controlled trial].
Liu X; Huang Y; Yang DL; Wei JL; He Y; Ma QL; Pang AM; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):502-6. PubMed ID: 23827107
[TBL] [Abstract][Full Text] [Related]
38. Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
Cho SY; Lee DG; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH; Kim YJ; Kim HJ; Min WS; Back H; Kang S; Lee EK
Clin Ther; 2015 Sep; 37(9):2019-27. PubMed ID: 26188835
[TBL] [Abstract][Full Text] [Related]
39. Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group.
Kimura SI; Fujita H; Kato H; Hiramoto N; Hosono N; Takahashi T; Shigeno K; Hatsumi N; Minamiguchi H; Miyatake J; Handa H; Akiyama N; Kanda Y; Yoshida M; Kiyoi H; Miyazaki Y; Naoe T;
Support Care Cancer; 2017 Nov; 25(11):3515-3521. PubMed ID: 28584934
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China.
Xu XH; Zhang L; Cao XX; Li J; Zhang W; Zhu TN; Cai HC; Chen M; Han X; Yang C; Han B; Zhang Y; Zhuang JL; Zhou DB; Duan MH
J Infect Chemother; 2017 Jun; 23(6):360-367. PubMed ID: 28341518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
